Evidence map›Paper›PMID 32614479›Full record

ArticleESC heart failure2020

Value of the CHA

Mony Shuvy, Donna R Zwas, Andre Keren, Israel Gotsman

Open access · goldAbstract read
In one paragraph

Article in ESC heart failure, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Role of the CHAThe Journal of international medical research · 2025
    Article
  11. Article
  12. Article
  13. Observational
  14. CHAFrontiers in cardiovascular medicine · 2025
    Article
  15. Article
  16. Article
  17. Review
  18. CHAAging clinical and experimental research · 2022
    Article
  19. Article
  20. Predictive Value of the CHAFrontiers in cardiovascular medicine · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Mony ShuvyHeart Institute, Hadassah University Hospital, Jerusalem, Israel.
Donna R ZwasHeart Institute, Hadassah University Hospital, Jerusalem, Israel.
Andre KerenHeart Institute, Hadassah University Hospital, Jerusalem, Israel.
Israel GotsmanHeart Institute, Hadassah University Hospital, Jerusalem, Israel.
Clalit Health Services · ILHadassah Academic College · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsComorbidities are highly prevalent in patients with heart failure (HF) and affect clinical outcome. The CHA METHODS AND

resultsWe evaluated the predictive value of this score on clinical outcome in patients with HF. All patients with a diagnosis of chronic HF at a health maintenance organization were evaluated for the CHA

conclusionsThe CHA

Indexed as

Atrial FibrillationHeart FailureStrokeThromboembolismHumansRisk AssessmentCHA2DS2-VASc scoreHeart failureOutcome

Identifiers

PMID32614479
PMCPMC7524134
OpenAlexW3039422990

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.